AVENUE THERAPEUTICS, INC. Quarterly Earnings Per Share, Diluted in USD/shares from Q3 2020 to Q3 2023

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary: Avenue Therapeutics, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q3 2020 to Q3 2023.
Avenue Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2023 was 0.06 USD/shares.
Avenue Therapeutics, Inc. annual Earnings Per Share, Diluted for 2021 was -0.22 USD/shares, a 29% increase from 2020.

Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)

Earnings Per Share, Diluted, Quarterly (USD/shares)

Earnings Per Share, Diluted, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023		$0.06	+$0.51		Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q3 2022	$0.07	$0	+$0.34	+43%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$0	$0	+$0.03	+50%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$0	$0	$0	-133%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$0	$0.69			Oct 1, 2021	Dec 31, 2021	10-K	2022-03-25
Q3 2021		-$1	-$1	-1217%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021		$0			Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021		$0			Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q3 2020		$0			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.